Aveanna Healthcare Outlines 2026 Revenue and EBITDA Targets Following Strong Q3 Growth
Aveanna Healthcare Holdings Inc. (AVAH) reported strong third-quarter financial results, highlighted by an 11.8% year-over-year increase in revenue to $695.5 million. The company also saw a significant 25% jump in adjusted EBITDA, which reached $100.1 million for the quarter. Looking ahead, management has provided optimistic long-term guidance, projecting annual revenue to exceed $2.695 billion and adjusted EBITDA to surpass $374 million by 2026. This growth strategy is being driven by an expansion in the company's preferred payer strategy.
Tickers: $AVAH